Bone Density

Most age-related fractures aren't really about old bones — they're about bones that never got loaded heavily enough to stay strong. The 2026 evidence has collapsed a long-standing public-health myth: walking and swimming don't meaningfully build bone in the hip and spine, but heavy resistance training does, and the protocol that does it is now defined by clinical trial.

Bone has been quietly reclassified over the last decade. It is no longer treated as inert structural scaffolding; it's a highly vascularized endocrine organ that secretes osteocalcin into the brain, traffics calcium between the skeleton and the arterial wall, and tracks all-cause mortality independent of fractures. The dominant intervention to defend it is mechanical — heavy, progressive resistance training with impact loading. Nutrition (protein, calcium, vitamin K2), chronobiology, and gut/endocrine status are the supporting cast.

Why bone is on the longevity short list

Three independent signals converge:

All-cause mortality. Low bone mineral density (BMD) is inversely associated with mortality across cohort after cohort, and the relationship persists after adjusting for age, sex, kidney function, and comorbidity.^[1] Counter-intuitively, osteopenia carries a higher adjusted hazard ratio for mortality (HR 1.37) than clinical osteoporosis (HR 1.06) — a paradox driven by the much larger osteopenic population, the rapid physiology of bone loss in that range, and frequent metabolic comorbidities.^[2] The mortality is not mostly from fractures. It's from cardiovascular disease, hypertension, and diabetes, all of which share microvascular and inflammatory biology with bone loss.
Osteosarcopenia is the lethal combination. When bone loss and muscle loss occur together, the pooled signal in 14,429 prospectively followed adults is RR 1.53 for all-cause mortality vs. healthy controls — and osteosarcopenia raises 3-year mortality risk by ~30% over isolated sarcopenia and ~8% over isolated low BMD.^[3] Mechanical and endocrine cycles couple the two: atrophied muscle stops loading bone and secretes inflammatory factors that suppress osteoblasts. Treating one without the other is incomplete.
The bone-vascular axis is bidirectional. As bone demineralizes, calcium does not simply excrete — it preferentially deposits in arterial walls, accelerating atherosclerosis and vascular stiffness.^[4] Pro-inflammatory cytokines from active bone loss (TNF-α, IL-6) damage vascular endothelium directly, and calcified arteries reciprocate by secreting sclerostin, Dkk-1, and SFRP — all of which inhibit osteoblast bone formation, locking the system into a feedback loop. You cannot defend the cardiovascular system without defending the skeleton.

A fourth, more recently appreciated link: bone is endocrine to the brain. Osteocalcin secreted by osteoblasts crosses the blood-brain barrier and binds GPR158 in the cortex and hippocampus, where it drives BDNF expression, supports long-term potentiation, and is required for normal spatial memory.^[5] Circulating osteocalcin declines in parallel with age-related cognitive decline; supplementing it (or stimulating its release through mechanical bone loading) reverses age-related deficits in animal models. This places resistance training squarely on the cognitive longevity short list — see Dementia prevention.

Beyond DXA: the Trabecular Bone Score

DXA — the standard areal-BMD measurement — quantifies how much mineral is present in a 2D projection. It says nothing about the 3D architecture or material quality of the trabecular matrix. That gap is now filled by the Trabecular Bone Score (TBS), a non-invasive index extracted from the same lumbar DXA image that captures trabecular connectivity and spacing.

TBS category	Score	Interpretation
Normal microarchitecture	> 1.31	Robust, well-connected trabecular network
Partially degraded	1.23 – 1.31	Onset of structural decay; intervene now
Degraded	< 1.23	High fragility-fracture risk and elevated mortality

The mortality signal from TBS is independent of BMD. In population cohorts, adults in the lowest TBS tier carry HR 1.47 for all-cause mortality and HR 2.07 for cancer-specific mortality, with the association robust to BMD adjustment.^[6] TBS also correlates inversely with visceral adipose tissue independent of total body weight — central adiposity actively damages spinal microarchitecture, which is one reason the metabolic-syndrome / osteoporosis combination is so lethal.

Practical takeaway: if you're getting a DXA in your 40s or 50s, ask for the TBS read-out. It catches structural deterioration well before BMD crosses a clinical threshold.

Heavy lifting beats walking by an order of magnitude

Bone is a piezoelectric, mechanosensitive tissue. Under high mechanical strain, fluid shear inside the osteocyte lacunar-canalicular network triggers electrical and biochemical signals that recruit osteoblasts (Wolff's Law). The body is metabolically lazy: it builds and maintains only the bone that habitual loading actually demands.

This is why the well-meaning "walk for your bones" guidance has aged poorly. Walking, swimming, light aerobics, and whole-body vibration plates do not exceed the minimum essential strain threshold in the hip and lumbar spine. They are excellent for the cardiovascular system; they do not move BMD.^[7] Whole-body vibration is the borderline case: 2025–2026 meta-analyses find a statistically significant but low-certainty effect on total-femur BMD only — not femoral neck or lumbar spine — confirming it is at best a modest adjunct for those who cannot perform impact loading, not a substitute.^[8] The intervention that does move spine and hip BMD is now well-defined.

The LIFTMOR protocol

The Australian LIFTMOR (Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation) trial randomized postmenopausal women with diagnosed osteopenia or osteoporosis to high-intensity resistance and impact training (HiRIT) vs. a low-intensity home program, twice weekly for 8 months under supervision.^[9] The protocol was deliberately aggressive against entrenched clinical fears that heavy loading would shatter fragile bone:

Compound barbell lifts: deadlift, overhead press, back squat, 5 sets × 5 reps at >80–85% 1RM.
Impact loading: jumping chin-ups with heavy drop landings.
Twice weekly, ~30 minutes per session, after a graded transition period.

Over 8 months the HiRIT group gained ~2.9% BMD at the lumbar spine and ~0.3% at the femoral neck with significant improvements in functional performance, vs. losses in the low-intensity arm. Subsequent trials with similar protocols (MEDEX-OP and others) have replicated the effect at ~2.5–4% BMD gains — and no fragility fractures or other serious adverse events have been reported in supervised heavy training of osteoporotic populations.^[10] Heavy progressive loading is both the most effective osteogenic stimulus available and safe when supervised, even in already-fragile bone.

How to dose osteogenic loading — the mechanostat rules

LIFTMOR tells you what to do; the mechanostat literature tells you how to dose it. Four rules follow from it, and they explain why ordinary activity fails. Evidence rating: Moderate — the dosing rules are well-replicated in animal loading models and the tennis-arm natural experiment, but the precise human force thresholds are extrapolations.

Force magnitude and rate, not volume, set the stimulus. Osteogenic thresholds in human jump-loading research sit around >3 body weights (BW) of ground-reaction force and >43 BW/s rate of force application. Heel drops generate ~4.9 BW; multidirectional/diagonal drop jumps produce the largest acute bone-formation marker (P1NP) response. Maximal countermovement and squat jumps may not exceed walking-level joint loading at the hip and ankle — the hard-force version of the "walking is not enough" thesis.
Mechanosensitivity saturates within a few cycles. Osteocytes desensitize rapidly, so piling on repetitions in one bout yields steeply diminishing returns. Dividing a daily dose into several short bouts — with ~4–8 hours of recovery between them to restore sensitivity — markedly enhanced the osteogenic response in the foundational rodent loading work.^[11] The practical rule is "little and often": short osteogenic bouts spread across the day complement (don't replace) the twice-weekly heavy session.
Loading is site-specific. Bone responds only where it is loaded. The cleanest demonstration is the tennis "natural experiment": the playing arm carries up to ~22% more bone mineral content than the non-playing arm in young players training 5 days/week (vs ~12% at 2 days/week), with even larger cortical asymmetry at the mid-radius.^[12] Choose movements that load the hip and spine specifically.
It reverses — bone training is maintenance, not a one-time deposit. In the ACTLIFE RCT of early-postmenopausal osteopenic women, the lumbar-spine BMD advantage over controls was lost after just 3 months of detraining, even though strength and power gains persisted longer.^[13] Programs must be continuous, not seasonal.

What the 2026 ACSM update endorses

The American College of Sports Medicine's 2026 Resistance Training Position Stand — synthesizing 137 systematic reviews and >30,000 participants — makes the prescription for bone explicit:^[14]

Resistance training at ≥70% 1RM, targeting all major muscle groups, at least twice weekly.
High-intensity (≥80% 1RM) protocols produce the largest standardized BMD gains across hip and spine.
Progressive overload is required; sub-threshold loading does not transfer to bone.

Mechanical silence is independently toxic

The International Osteoporosis Foundation's 2025 position is that prolonged sedentary behavior is an independent risk factor for bone loss, irrespective of whether you train.^[15] The mechanism: extended hours of mechanical silence trigger osteocyte apoptosis and downregulate the same anabolic signaling that loading turns on. The implication parallels the active-couch-potato finding for cardiovascular risk — see Sitting. One LIFTMOR session is not a license for nine sedentary hours. Habitual movement, frequent posture change, and a step floor matter for bone as well as heart.

Protein, calcium, and the vitamin K2 traffic problem

Protein is anabolic to bone, not catabolic

The decades-old claim that high-protein diets "leach calcium from the bones" via metabolic acidosis has been categorically rejected by modern systematic reviews. The opposite is true: dietary protein is required for both osteogenesis and bone matrix integrity.^[16] High-quality protein activates mTORC1 (via leucine), upregulates IGF-1 (which stimulates renal calcitriol production and intestinal calcium absorption), and provides the amino acids the bone matrix is built from.

Targets converge on 1.2–1.6 g/kg/day for healthy midlife adults, with 1.6–2.0 g/kg/day appropriate for older adults, those with established osteopenia, or anyone in a caloric deficit (including GLP-1 users — see GLP-1). The historical EFSA / FAO PRI of 0.83 g/kg is now considered inadequate for skeletal preservation in adulthood. See Protein for the full evidence base.

Calcium intake is falling and anti-nutrient intake is rising

A serial NHANES analysis (1999–2023, n > 50,000) documented a sharp population-level shift: mean dietary calcium dropped from 1,025 → 900 mg/day, mean phytate intake rose from 594 → 834 mg/day, mean oxalate intake rose from 242 → 281 mg/day, and mean femoral-neck BMD fell from 0.849 to 0.775 g/cm² in parallel.^[17] The combination of less calcium, more anti-nutrient binding, and likely reductions in habitual mechanical loading is showing up in the population-level skeleton.

Anti-nutrients matter for plant-source calcium specifically:

Source	Calcium content	Anti-nutrients	Net bioavailability
Spinach	High	Very high oxalate	Poor — most calcium is bound and excreted
Kale, bok choy	Moderate	Low oxalate	High — counts as bioavailable plant calcium
Almonds, sesame	Moderate	Phytate	Moderate; soaking/sprouting helps
Whole grain millet, teff	High	Very high phytate	Poor without dephytinization (soaking, fermenting)
Dairy (yogurt, kefir, cheese)	High	None	High; the population reference for bioavailability

If supplementing to reach 1,000–1,200 mg/day total, the chemical form matters:^[18]

Calcium carbonate — 40% elemental calcium, cheapest, requires gastric acid (take with meals). Frequently causes constipation/bloating. Poorly absorbed in adults on PPIs.
Calcium citrate — 21% elemental, absorbed independent of stomach acid, can be taken on an empty stomach. The right choice for older adults, anyone on acid-reducing medication, or anyone with reflux.
Calcium hydroxyapatite — slower, more stable absorption; mimics bone matrix. Reasonable but usually unnecessary.

Vitamin K2 directs the traffic

Calcium delivered without proper routing risks landing in arterial walls rather than bone. Vitamin K2 carboxylates osteocalcin (drawing calcium into the skeleton) and Matrix Gla Protein (clearing calcium out of soft tissue and vasculature).^[19] The two clinically relevant subtypes:

MK-4 — short half-life, fast tissue uptake. The only K2 form with high-dose RCT data showing reductions in vertebral and non-vertebral fractures (Japanese cohorts, pharmacological doses ~45 mg/day). Requires multiple daily doses to maintain status.
MK-7 — long half-life (~3 days), once-daily dosing supports continuous carboxylation status. Strong mechanistic and biomarker support; lacks the fracture-endpoint trials of high-dose MK-4.

For most healthy adults the practical choice is MK-7 at 90–180 µg/day, paired with vitamin D3 and adequate magnesium. Don't take K2 supplementally if you're on warfarin without coordinating with the prescriber. See Vitamin K2 for the full evidence picture and Vitamin D.

Where the nutrition evidence has shifted

Two corrections and two positive food trials are worth folding into the picture:

Vitamin D in already-replete adults does not cut fractures. The VITAL fracture ancillary randomized 25,871 generally replete adults to 2,000 IU/day vitamin D3 and found no reduction in total, non-vertebral, or hip fractures, including in those with low BMD or taking calcium.^[20] The nuance: correcting deficiency matters; supplementing the replete does not. See Vitamin D and Calcium for the dosing detail. Evidence rating: Strong.
Excess preformed vitamin A (retinol) raises hip-fracture risk. A meta-analysis of 283,930 participants found high retinol intake raised hip-fracture risk (adjusted RR 1.40, 95% CI 1.03–1.91) and high total vitamin A (RR 1.29, 95% CI 1.07–1.57); beta-carotene did not.^[21] A "more is not better" caution against high-dose retinol supplements, large amounts of liver, and cod-liver-oil megadosing. Evidence rating: Moderate.
Prunes (50 g/day) preserve hip BMD. In a 12-month RCT of 235 postmenopausal women, the 50 g/day dose (~4–6 prunes) held total-hip BMD steady while controls lost ~1%; the 100 g/day arm showed no significant hip benefit and had high dropout — so the actionable dose is 50 g, not 100 g.^[22] Evidence rating: Moderate.
Collagen peptides (5 g/day) raised BMD in one RCT. 5 g/day specific collagen peptides for 12 months increased lumbar-spine and femoral-neck BMD and raised P1NP in 131 postmenopausal women with low BMD; a 2025 meta-analysis found benefit greatest when combined with calcium and vitamin D.^[23] Several such trials are industry-linked. Evidence rating: Weak / preliminary.

The older "alkaline diet / acid-ash leaches calcium from bone" narrative does not hold up: alkaline potassium salts reduce urinary calcium, but systematic reviews find insufficient evidence that dietary acid load causes BMD loss or fractures — mechanistically plausible, not established. This parallels the protein-acidosis myth above.

Cortisol, insulin resistance, and the gut

Chronic stress damages bone through a specific protein

Chronic glucocorticoid elevation — prescription steroids, but also persistent endogenous cortisol from psychological stress — degrades bone profoundly. Mild Autonomous Cortisol Secretion (MACS) is associated with significantly lower TBS, lower trabecular volume, and reduced osteocalcin even in patients whose cortisol levels are barely outside the normal reference range. The mechanism was clarified in 2025: glucocorticoids activate a protein called Basigin in skeletal stem cells, which simultaneously disrupts cellular regeneration and inhibits the formation of the type-H blood vessels bones depend on.^[24] Antibody blockade of Basigin restores bone mass in animal models, opening a plausible therapeutic class.

A Mendelian-randomization analysis adds practical detail: up to ~8% of the cortisol-induced osteoporosis effect at the lumbar spine is mediated through sarcopenia.^[25] Translation: resistance training is not just additive to stress management for bone — it directly cancels a meaningful slice of the pathway. See Stress.

Insulin resistance uncouples bone density from bone strength

Hyperinsulinemia and the obesity that often accompanies insulin resistance can paradoxically raise DXA-measured BMD — the bone is loaded by extra body weight and exposed to anabolic insulin. But the bone quality in insulin-resistant adults is worse: advanced glycation end-products (AGEs) accumulate in the collagen matrix, micro-indentation testing shows reduced bending and impact strength, and serum osteocalcin drops.^[26] A "normal" DXA in a metabolically unhealthy adult should not be reassuring. Glycemic control and insulin sensitivity belong on the bone-health checklist, which makes the dietary pattern, exercise, and sleep prescriptions for Metabolic flexibility directly relevant.

The gut-bone axis

A diverse, fiber-fermenting microbiome produces short-chain fatty acids (butyrate, propionate, acetate) that suppress osteoclast differentiation and enhance paracellular calcium absorption. Conversely, dysbiosis raises systemic TNF-α and IL-6 and shifts the balance toward bone resorption.^[27] Probiotic strain-specific evidence is strongest for Lactobacillus rhamnosus GG and Lactobacillus reuteri, both of which have shown improvements in bone mineral content in RCTs. The general dietary lever is the same one that protects everything else: high plant diversity, polyphenols, fermented foods, adequate fiber. See Fermented foods.

Chronobiology: the nocturnal resorption peak

Bone resorption is not constant. Continuous serum sampling shows that CTX (the C-terminal telopeptide of type I collagen, a resorption marker) rises sharply at night during the fasting/sleeping phase, while bone formation markers stay relatively flat across the 24 hours.^[28] The circadian gene BMAL1 normally suppresses osteoclast activity; circadian disruption (chronic shift work, sustained sleep deprivation, evening blue-light exposure) lowers BMAL1, removes the brake, and accelerates net bone loss.

This has practical chronotherapy implications:^[29]

Intervention	Optimal timing	Mechanism
Calcium supplementation	Evening / pre-sleep	A 1,000 mg dose before bed reduces overnight CTX by ~20%; morning dosing has no resorption effect
Mechanical loading (training)	Morning / active phase	Anabolic response peaks during the active metabolic window; morning light fixes circadian phase
Time-restricted eating	Daytime 8–12h window	Postprandial GLP-2 release suppresses daytime resorption; eating-clock alignment stabilizes total BMC
Teriparatide (rare clinical)	Morning	12-month trial: 9.1% lumbar BMD gain morning vs. 4.8% evening
Salmon calcitonin (rare clinical)	Evening	Evening administration achieves 75% CTX inhibition vs. 40–50% morning

For a healthy adult the actionable items are simple: train earlier in the day when feasible, take calcium with the evening meal rather than at breakfast, eat in a daytime window, and protect sleep — see Sleep and Circadian rhythms. Shift workers carry an independent bone-loss risk that is hard to fully neutralize and worth flagging.

Sex steroids and the timing of bone loss

The perimenopausal rapid-loss window

The fastest bone loss of a woman's life is not gradual age-related decline — it is the first ~5–7 years around menopause, driven by estrogen withdrawal rather than aging per se, when a substantial fraction of spine and hip bone mass can be lost. This makes the timing of any intervention decisive. On hormone therapy, the "timing hypothesis" favors early initiation: a meta-analysis found HT cut non-vertebral fractures overall (RR 0.73) with a stronger effect in women under 60 (RR 0.67; hip/wrist RR 0.45).^[30] The Menopause Society's 2022 position affirms HT for prevention of bone loss and fracture in appropriate candidates. Evidence rating: Strong for the loss window; HT decisions are individual and belong with a clinician.

Male osteoporosis — and why estradiol, not testosterone, runs the show

Men are badly under-served by bone care: roughly 30% of hip fractures occur in men, and men carry about double the one-year post-hip-fracture excess mortality of women.^[31] The counterintuitive mechanism: estradiol — not testosterone — is the dominant sex steroid regulating bone resorption in men. Finkelstein's selective-suppression experiments showed estradiol deficiency, independent of testosterone, drives the rise in bone resorption.^[32] In the Testosterone Trials bone substudy of older men, testosterone raised spine trabecular volumetric BMD by ~7.5% over a year, with the gain correlating more tightly with the rise in estradiol than testosterone — but the trial was underpowered for fractures, and the later TRAVERSE bone subtrial did not show fracture reduction.^[33] Treat this as a BMD/strength signal, not validated anti-fracture therapy. The Endocrine Society advises screening all men ≥70, and men 50–69 with risk factors. Evidence rating: Moderate.

A practical corollary: several common chronic medications drive secondary bone loss and warrant DXA/FRAX awareness rather than reflexive discontinuation — glucocorticoids (the most potent), proton-pump inhibitors (long-term use raised hip-fracture risk ~30% in meta-analysis), SSRIs, aromatase inhibitors, and androgen-deprivation therapy. Discuss lowest effective dose and deprescribing of unnecessary chronic PPIs with the prescriber.

A note on weight loss and GLP-1

Rapid weight loss — including with GLP-1 receptor agonists — lowers BMD, especially at the hip, through reduced mechanical loading, lean-mass loss, and inadequate protein/calcium/vitamin D rather than a direct drug toxicity. The mitigation is the same prescription this page already makes: resistance and impact training, ≥1.2–1.6 g/kg protein, and adequate calcium and vitamin D alongside any intentional weight loss. Evidence rating: Moderate.

What's coming: the regenerative pipeline

Three preclinical / early-clinical programs may shift the therapeutic landscape over the next 5–10 years, but none is currently a substitute for mechanical loading and nutrition in a healthy adult:

GPR133 / AP503 — A newly characterized bone receptor whose pharmacological activation (compound AP503) substantially boosted BMD in mammalian models and reversed osteoporotic damage in animals.^[34] A potential anabolic class distinct from bisphosphonates.
CCN3 — A maternal-brain hormone that maintains skeletal density during the calcium drain of breastfeeding. UC Davis-led work shows CCN3 directly activates skeletal stem cells; localized hydrogel delivery accelerated fracture healing in mice.^[35]
ARPA-H NITRO program — A federally funded fast-track for in vivo regeneration of bone and articular cartilage, with first-in-human IND-enabling studies underway.^[36]

The point is to understand that the field is moving from antiresorptive maintenance (bisphosphonates, denosumab) toward genuine structural rebuilding. The point is not to defer mechanical loading and nutrition while waiting — those interventions remain the floor against which any future drug will be added.

A practical bone-density protocol for healthy midlife adults

Get a baseline DXA + TBS in your late 40s or early 50s — earlier if you have steroid exposure, eating-disorder history, premature menopause, family history, or chronic kidney disease. Repeat every 3–5 years; sooner if values drop into "partially degraded."
Lift heavy, twice a week. Compound barbell movements (squat, hinge, vertical/horizontal press, vertical/horizontal pull) at ≥80% 1RM, 5–8 reps, supervised initially. The LIFTMOR-style protocol is safe even in low-bone-mass populations when coached, and is the single most osteogenic stimulus available. See Resistance training.
Add impact loading. Once strength tolerates it: jump squats, low-box jumps, or jumping chin-up drop landings. 50–100 ground-reaction-force exposures per week is enough to register at the hip.
Don't sit through the rest of the day. A 7,000-step floor and hourly posture breaks. Mechanical silence has its own bone signal independent of the gym session — see Sitting.
- Train balance to prevent the fall. Nearly every fragility fracture requires a fall, so fall prevention is half the equation. Tai Chi reduces fallers (RR 0.76) and is a low-impact complement for older or deconditioned readers, even though it does little for BMD itself.^[37] See Mobility and balance.
Protein 1.2–1.6 g/kg/day (1.6–2.0 if older or in a caloric deficit), spread across three or four meals at ~30–40 g each. See Protein.
Calcium 1,000–1,200 mg/day, with the evening meal. Prefer dairy / kale / bok choy over spinach for plant sources. Calcium citrate if you take a PPI or have low gastric acid — and supplement only the gap, never as a large isolated bolus. See Calcium.
Vitamin D3 to a 25(OH)D of ~30–50 ng/mL plus vitamin K2 (MK-7) ~90–180 µg/day to direct the calcium into bone rather than artery. See Vitamin D.
Adequate magnesium (300–400 mg/day from food + supplement if needed) — required cofactor for vitamin D activation.
Treat metabolic and adrenal health as bone health. Visceral adiposity, insulin resistance, and chronic high cortisol all damage the matrix in ways DXA may miss. See Metabolic flexibility and Stress.
Sleep close to 8 hours. It's the window in which the cortisol-driven Basigin pathway gets reset and the circadian brake on osteoclasts is restored. Shift work is a flagged risk factor.
Don't smoke; cap alcohol. Both are direct ototoxic and osteotoxic — see Alcohol.

What's overhyped or wrong

"Walking is enough for bones." The mechanical strain produced by ambulation is below the osteogenic threshold for the hip and lumbar spine in midlife. Walking is excellent cardiovascular care. It does not move BMD.
"Calcium and vitamin D will protect my skeleton." Necessary, not sufficient. Without mechanical loading the substrate has no signal to assemble around.
"Heavy lifting will break my fragile bones." LIFTMOR and follow-on trials specifically tested this in adults already diagnosed with osteopenia and osteoporosis under supervision and reported zero fragility fractures. The 20th-century habit of prescribing only low-impact exercise to high-risk patients is one of the most expensive pieces of received wisdom in geriatric medicine.
"Whole-body vibration plates build bone." Modest at best in meta-analyses; not a substitute for progressive resistance with impact.
"Spinach is a great calcium source." Oxalate binds the calcium; net bioavailability is poor. Eat spinach for other reasons.
"DXA looks normal, so my bones are fine." DXA misses microarchitectural decay (TBS catches more), and in insulin-resistant adults it can be falsely reassuring because AGEs compromise bone quality without a density change.
"Generic bone-health supplement stacks fix it." Most commercial blends are under-dosed on K2, over-dosed on undirected calcium, or built around evidence-light ingredients (e.g., strontium citrate). The targeted stack is plain: D3 + K2 (MK-7) + magnesium + adequate dietary protein + calcium adjusted to dietary intake.
"Stem cells / GPR133 / CCN3 will fix it soon." Promising, but preclinical or early-clinical. Mechanical loading is the only intervention with a 30-year evidence base and a today-actionable protocol.